Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 04, 2024, titled "Sentynl Therapeutics announces global acquisition of Zokinvy�� (Lonafarnib) for treatment of Hutchinson-Gilford Progeria Syndrome from Eiger Biopharmaceuticals".